TY - JOUR
T1 - Alterations of regional alveolar oxygen tension in asymptomatic current smokers
T2 - Assessment with hyperpolarized 3He MR imaging
AU - Hamedani, Hooman
AU - Kadlecek, Stephen J.
AU - Ishii, Masaru
AU - Xin, Yi
AU - Emami, Kiarash
AU - Han, Biao
AU - Shaghaghi, Hoora
AU - Gopstein, Diana
AU - Cereda, Maurizio
AU - Gefter, Warren B.
AU - Rossman, Milton D.
AU - Rizi, Rahim R.
N1 - Publisher Copyright:
© 2014 RSNA.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Purpose: To assess the ability of helium 3 (3He) magnetic resonance (MR) imaging of regional alveolar partial pressure of oxygen (Pao2) to depict smoking-induced functional alterations and to compare its efficacy to that of current diagnostic techniques. Materials and Methods: This study was approved by the local institutional review board and was compliant with HIPAA. All subjects provided informed consent. A total of 43 subjects were separated into three groups: nonsmokers, asymptomatic smokers, and symptomatic smokers. All subjects underwent a Pao2 imaging session followed by clinically standard pulmonary function tests (PFTs), the 6-minute walk test, and St George Respiratory Questionnaire (SGRQ). The whole-lung mean and standard deviation of Pao2 were compared with metrics derived from PFTs, the 6-minute walk test, and the SGRQ. A logistic regression model was developed to identify the predictors of alterations to the lungs of asymptomatic smokers. Results: The whole-lung standard deviation of Pao2 correlated with PFT metrics (forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC], Pearson r = 20.69, P <.001; percentage predicted FEV1, Pearson r = 20.67, P <.001; diffusing capacity of lung for carbon monoxide [Dlco], Pearson r = 20.45, P =.003), SGRQ score (Pearson r = 0.67, P <.001), and distance walked in 6 minutes (Pearson r = 20.47, P =.002). The standard deviation of Pao2 was significantly higher in asymptomatic smokers than in nonsmokers (change in the standard deviation of Pao2 = 7.59 mm Hg, P =.041) and lower when compared with symptomatic smokers (change in the standard deviation of Pao2 = 10.72 mm Hg, P =.001). A multivariate prediction model containing FEV1/FVC and the standard deviation of Pao2 (as significant predictors of subclinical changes in smokers) and Dlco (as a confounding variable) was formulated. This model resulted in an area under the receiver operating characteristic curve with a significant increase of 29.2% when compared with a prediction model based solely on nonimaging clinical tests. Conclusion: The 3He MR imaging heterogeneity metric (standard deviation of Pao2) enabled the differentiation of all three study cohorts, which indicates that it can depict smoking-related functional alterations in asymptomatic current smokers.
AB - Purpose: To assess the ability of helium 3 (3He) magnetic resonance (MR) imaging of regional alveolar partial pressure of oxygen (Pao2) to depict smoking-induced functional alterations and to compare its efficacy to that of current diagnostic techniques. Materials and Methods: This study was approved by the local institutional review board and was compliant with HIPAA. All subjects provided informed consent. A total of 43 subjects were separated into three groups: nonsmokers, asymptomatic smokers, and symptomatic smokers. All subjects underwent a Pao2 imaging session followed by clinically standard pulmonary function tests (PFTs), the 6-minute walk test, and St George Respiratory Questionnaire (SGRQ). The whole-lung mean and standard deviation of Pao2 were compared with metrics derived from PFTs, the 6-minute walk test, and the SGRQ. A logistic regression model was developed to identify the predictors of alterations to the lungs of asymptomatic smokers. Results: The whole-lung standard deviation of Pao2 correlated with PFT metrics (forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC], Pearson r = 20.69, P <.001; percentage predicted FEV1, Pearson r = 20.67, P <.001; diffusing capacity of lung for carbon monoxide [Dlco], Pearson r = 20.45, P =.003), SGRQ score (Pearson r = 0.67, P <.001), and distance walked in 6 minutes (Pearson r = 20.47, P =.002). The standard deviation of Pao2 was significantly higher in asymptomatic smokers than in nonsmokers (change in the standard deviation of Pao2 = 7.59 mm Hg, P =.041) and lower when compared with symptomatic smokers (change in the standard deviation of Pao2 = 10.72 mm Hg, P =.001). A multivariate prediction model containing FEV1/FVC and the standard deviation of Pao2 (as significant predictors of subclinical changes in smokers) and Dlco (as a confounding variable) was formulated. This model resulted in an area under the receiver operating characteristic curve with a significant increase of 29.2% when compared with a prediction model based solely on nonimaging clinical tests. Conclusion: The 3He MR imaging heterogeneity metric (standard deviation of Pao2) enabled the differentiation of all three study cohorts, which indicates that it can depict smoking-related functional alterations in asymptomatic current smokers.
UR - http://www.scopus.com/inward/record.url?scp=84921770399&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921770399&partnerID=8YFLogxK
U2 - 10.1148/radiol.14132809
DO - 10.1148/radiol.14132809
M3 - Article
C2 - 25322340
AN - SCOPUS:84921770399
SN - 0033-8419
VL - 274
SP - 585
EP - 596
JO - RADIOLOGY
JF - RADIOLOGY
IS - 2
ER -